Skip to main content

Advertisement

ADVERTISEMENT

Medical Services

08/21/2019
A study in which Michigan surgical patients received reduced amounts of opioids post-surgery has found that the change did not result in an overall worsening of pain or patient satisfaction.
A study in which Michigan surgical patients received reduced amounts of opioids post-surgery has found that the change did not result in an overall worsening of pain or patient satisfaction.
A study in which Michigan...
08/21/2019
Addiction Professional
08/18/2019
There was universal agreement among panelists during a Sunday morning session at the National Conference on Addiction Disorders East about the benefits of harm reduction strategies. They prevent overdose deaths and the spread of infectious...
There was universal agreement among panelists during a Sunday morning session at the National Conference on Addiction Disorders East about the benefits of harm reduction strategies. They prevent overdose deaths and the spread of infectious...
There was universal agreement...
08/18/2019
Addiction Professional
News
08/05/2019
Sunovion Pharmaceuticals announced last week that the Food and Drug Administration (FDA) has accepted its New Drug Application for dasotraline for the treatment of moderate to severe binge eating disorder. The FDA's action date for the novel...
Sunovion Pharmaceuticals announced last week that the Food and Drug Administration (FDA) has accepted its New Drug Application for dasotraline for the treatment of moderate to severe binge eating disorder. The FDA's action date for the novel...
Sunovion Pharmaceuticals...
08/05/2019
Addiction Professional
News
08/05/2019
A new study suggests that a more conservative approach to medicating infants born with neonatal opioid withdrawal syndrome (NOWS) can lead to shorter hospital stays and more effective outcomes.
A new study suggests that a more conservative approach to medicating infants born with neonatal opioid withdrawal syndrome (NOWS) can lead to shorter hospital stays and more effective outcomes.
A new study suggests that a more...
08/05/2019
Addiction Professional
News
08/02/2019
An Ohio partnership designed to reduce opioid use in the hard-hit state conducted a training this week to encourage physicians, nurse practitioners and physician assistants to offer medication-assisted treatment in a variety of care...
An Ohio partnership designed to reduce opioid use in the hard-hit state conducted a training this week to encourage physicians, nurse practitioners and physician assistants to offer medication-assisted treatment in a variety of care...
An Ohio partnership designed to...
08/02/2019
Addiction Professional
News
07/31/2019
A new website in California is serving as a hub for treatment providers and the public to access information about the state's response to the opioid crisis. The research and consulting firm Health Management Associates has spearheaded...
A new website in California is serving as a hub for treatment providers and the public to access information about the state's response to the opioid crisis. The research and consulting firm Health Management Associates has spearheaded...
A new website in California is...
07/31/2019
Addiction Professional
News
07/29/2019
A federal judge last week ordered the Food and Drug Administration (FDA) to reconsider its decision to grant market exclusivity to the first approved injectable formulation of buprenorphine for opioid dependence.
A federal judge last week ordered the Food and Drug Administration (FDA) to reconsider its decision to grant market exclusivity to the first approved injectable formulation of buprenorphine for opioid dependence.
A federal judge last week...
07/29/2019
Addiction Professional
07/19/2019
The National Institutes of Health (NIH) has identified vaccine development as a high-priority area in the effort to combat the opioid epidemic. NIH funding is bringing together experts from the substance use and vaccine research communities...
The National Institutes of Health (NIH) has identified vaccine development as a high-priority area in the effort to combat the opioid epidemic. NIH funding is bringing together experts from the substance use and vaccine research communities...
The National Institutes of...
07/19/2019
Addiction Professional
07/15/2019
The many barriers to access to medication treatments for opioid use disorder justify considering “novel and potentially controversial solutions,” in the words of two Boston University-based physicians writing last week in JAMA. They suggest...
The many barriers to access to medication treatments for opioid use disorder justify considering “novel and potentially controversial solutions,” in the words of two Boston University-based physicians writing last week in JAMA. They suggest...
The many barriers to access to...
07/15/2019
Addiction Professional
06/24/2019
On-site availability of buprenorphine for opioid addiction is now one of the prominent components of New York City's comprehensive syringe service programs.
On-site availability of buprenorphine for opioid addiction is now one of the prominent components of New York City's comprehensive syringe service programs.
On-site availability of...
06/24/2019
Addiction Professional

Advertisement

Advertisement